Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -28.46%-16.03M | 22.29%-9M | 36.01%-9.69M | 43.91%-55.68M | 33.02%-16.49M | 50.96%-12.48M | 51.57%-11.58M | 40.18%-15.14M | -33.47%-99.27M | -11.53%-24.61M |
| Net income from continuing operations | -11.75%-12.94M | 12.66%-10.56M | 32.20%-8.94M | 37.08%-50.27M | 34.74%-13.41M | 50.41%-11.58M | 24.11%-12.09M | 34.26%-13.18M | 11.22%-79.89M | 16.69%-20.54M |
| Operating gains losses | -157.62%-969.34K | -94.01%19.69K | -110.24%-33.13K | 145.52%1.49M | -316.25%-842.01K | 530.44%1.68M | --328.36K | --323.5K | -170.30%-3.28M | 3,301.84%389.38K |
| Depreciation and amortization | -6.52%183.18K | 0.55%205.79K | -9.89%193.39K | -13.46%813.65K | -11.50%198.42K | -13.65%195.96K | -14.18%204.66K | -14.36%214.62K | 6.79%940.21K | -3.77%224.21K |
| Asset impairment expenditure | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- | --1.01M | --1M |
| Unrealized gains and losses of investment securities | 152.05%577.99K | -161.72%-456.11K | -166.59%-177.79K | -74.02%1.05M | 4,897.07%1.16M | -170.21%-1.11M | 39.65%739K | -86.03%267K | -72.92%4.05M | 102.84%23.13K |
| Remuneration paid in stock | 305.68%766.16K | 1,902.21%1.51M | -127.69%-152.55K | -36.97%889.05K | -64.28%73.8K | -33.79%188.86K | -80.57%75.49K | 3.89%550.9K | -83.38%1.41M | -97.07%206.61K |
| Other non cashItems | -7.23%-3.49M | 8.64%-750.51K | 98.01%-69.25K | 52.18%-10.95M | -3.63%-3.4M | 55.08%-3.26M | 88.14%-821.44K | 36.18%-3.48M | -33.54%-22.91M | 29.80%-3.28M |
| Change In working capital | -110.61%-149.21K | 14,415.39%1.04M | -423.51%-513.27K | 313.87%1.29M | 89.95%-264.55K | -49.87%1.41M | -100.42%-7.24K | 106.33%158.66K | -115.96%-604.65K | -425.06%-2.63M |
| -Change in receivables | -167.48%-672.03K | -116.70%-97.58K | 1.43%1.23M | 572.39%1.09M | -225.51%-455K | -184.52%-251.25K | -74.15%584.16K | 143.83%1.21M | 82.75%-230.68K | 270.78%362.52K |
| -Change in prepaid assets | -385.36%-694.6K | -1,371.35%-69.99K | 275.26%790.75K | 139.97%38.82K | -107.28%-24.04K | 58.66%-143.11K | 93.40%-4.76K | 2,492.65%210.72K | -112.83%-97.1K | 287.98%329.98K |
| -Change in payables and accrued expense | -32.45%1.22M | 305.50%1.21M | -114.64%-2.71M | 196.45%164.64K | 106.45%214.48K | -44.50%1.8M | -50.99%-586.65K | -522.03%-1.26M | -103.94%-170.69K | -435.69%-3.33M |
| -Change in other current assets | --988 | ---- | ---- | --0 | --0 | --0 | --0 | --0 | -379.36%-106.18K | --0 |
| -Change in other working capital | ---- | ---- | --179.7K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -28.46%-16.03M | 22.29%-9M | 36.01%-9.69M | 43.91%-55.68M | 33.02%-16.49M | 50.96%-12.48M | 51.57%-11.58M | 40.18%-15.14M | -33.47%-99.27M | -11.53%-24.61M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 73.38%-406.14K | 862.02%3.09M | -776.12%-434.36K | 32.18%-3.01M | -127.68%-1.03M | 48.14%-1.53M | -2.02%-404.97K | 92.32%-49.58K | -501.18%-4.44M | 70.42%-451.79K |
| Capital expenditure reported | ---- | ---- | ---- | 66.50%-5.55K | ---- | ---- | ---- | ---- | -1.66%-16.57K | ---- |
| Net PPE purchase and sale | 90.49%-231.69K | 40.46%-134.26K | -452.59%-676.92K | -165.64%-4.48M | -284.84%-1.7M | -711.53%-2.44M | 25.38%-225.48K | 80.96%-122.5K | 69.61%-1.69M | 70.90%-440.59K |
| Net investment purchase and sale | --0 | 826.06%507.68K | --244.96K | 141.61%1.1M | --409.59K | 124.01%633.4K | --54.82K | --0 | -154.66%-2.64M | --0 |
| Interest received (cash flow from investment activities) | --0 | --0 | --0 | --378.04K | --148.35K | --77.61K | --76.76K | --75.32K | --0 | --0 |
| Net other investing changes | -223.95%-242.33K | 1,003.70%2.78M | 0.00%-2.4K | ---- | ---- | 6,693.90%195.51K | -224.71%-307.67K | 0.00%-2.4K | ---94.75K | --5.37K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 73.38%-406.14K | 862.02%3.09M | -776.12%-434.36K | 32.18%-3.01M | -127.68%-1.03M | 48.14%-1.53M | -2.02%-404.97K | 92.32%-49.58K | -501.18%-4.44M | 70.42%-451.79K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 2,246.60%21.12M | 330.27%60M | -98.48%175.01K | -64.04%27.12M | -98.62%731.52K | -93.01%900K | 45.13%13.95M | 29,590.17%11.54M | 32.80%75.43M | 6.95%52.98M |
| Net issuance payments of debt | 66.78%-10.43K | 40.52%-21.83K | 42.19%-21.65K | 6.92%-134K | 24.12%-28.45K | 20.13%-31.4K | -5.85%-36.7K | -15.32%-37.45K | -18.22%-143.96K | -4.20%-37.5K |
| Net common stock issuance | 1,457.87%20M | 342.04%63.48M | --0 | -65.16%27.52M | --0 | -90.24%1.28M | 46.08%14.36M | --11.88M | 50.31%78.99M | 7.48%56.01M |
| Cash dividends paid | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Proceeds from stock option exercised by employees | --1.44M | 75.71%153.75K | --201.88K | 555.25%862.5K | --775K | --0 | --87.5K | --0 | -98.29%131.63K | --0 |
| Interest paid (cash flow from financing activities) | 43.48%-3.41K | 24.29%-4.26K | 26.29%-5.22K | 7.43%-25.11K | 13.62%-6.38K | 15.24%-6.03K | 5.53%-5.62K | -6.06%-7.08K | ---27.12K | ---7.38K |
| Net other financing activities | 11.05%-308.09K | ---- | ---- | 68.60%-1.1M | 99.71%-8.65K | -12.07%-346.37K | ---460.3K | ---289.04K | -5.50%-3.52M | -17.66%-2.98M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 2,246.60%21.12M | 330.27%60M | -98.48%175.01K | -64.04%27.12M | -98.62%731.52K | -93.01%900K | 45.13%13.95M | 29,590.17%11.54M | 32.80%75.43M | 6.95%52.98M |
| Net cash flow | ||||||||||
| Beginning cash position | 27.18%66.42M | -75.39%12.37M | -58.58%22.32M | -34.42%53.88M | 50.61%39.11M | 25.93%52.23M | -10.53%50.25M | -34.42%53.88M | -18.23%82.17M | -53.81%25.97M |
| Current changes in cash | 135.76%4.69M | 2,653.58%54.09M | -172.65%-9.95M | -11.63%-31.57M | -160.12%-16.78M | 15.50%-13.1M | 113.37%1.96M | 85.96%-3.65M | -54.38%-28.28M | 7.60%27.92M |
| Effect of exchange rate changes | 293.34%30.29K | -507.84%-40.43K | -102.87%-476 | --2.86K | ---7.98K | ---15.67K | --9.91K | --16.6K | --0 | --0 |
| End cash Position | 81.89%71.14M | 27.18%66.42M | -75.39%12.37M | -58.58%22.32M | -58.58%22.32M | 50.61%39.11M | 25.93%52.23M | -10.53%50.25M | -34.42%53.88M | -34.42%53.88M |
| Free cash from | -8.60%-16.19M | 22.08%-9.2M | 32.09%-10.37M | 40.42%-60.17M | 27.46%-18.19M | 42.08%-14.91M | 51.25%-11.8M | 41.19%-15.27M | -26.30%-100.99M | -6.19%-25.07M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.